Literature DB >> 27446412

FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases.

Gian Franco Zannoni1, Giuseppina Improta2, Marco Petrillo3, Angela Pettinato4, Giovanni Scambia3, Filippo Fraggetta4.   

Abstract

Granulosa cell tumors (GCTs) of the ovary are uncommon neoplasms, accounting for ~5% of all malignant ovarian tumors. GCTs are a relatively homogeneous group of tumors, categorized into two distinct subtypes, juvenile GCT and adult GCT (AGCT), likely arising from a limited set of molecular events usually involving the disruption of pathways that regulate granulosa cell proliferation. In the present study, the presence of forkheadbox L2 (FOXL2) c.402C>G mutation was investigated in a series of 42 samples of primary and metastatic AGCT of the ovary. The samples consisted of 37 primary and 5 metastatic ovarian AGCTs from 37 patients. FOXL2 mutational status was evaluated using a pyrosequencing approach on 2.5-µm sections of formalin-fixed paraffin-embedded tissue. FOXL2 c.402C>G mutation was found in 33/37 (89.2%) primary AGCTs and in 4/5 (80.0%) metastases, with the molecular status of the metastases recapitulating that of the primary tumors (4 mutated cases and 1 wild-type case). Overall, FOXL2 mutation is present in the majority of primary and metastatic AGCTs, and could be used as a valid tool in the diagnosis of the disease and in cases of metastatic lesions from an unknown primary origin. Moreover the concordance of FOXL2 molecular status in primary and associated metastases suggests its early appearance and genomic stability in AGCT tumorigenesis.

Entities:  

Keywords:  FOXL2; granulosa cell tumors; molecular signatures; mutation; ovary

Year:  2016        PMID: 27446412      PMCID: PMC4950087          DOI: 10.3892/ol.2016.4711

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  FOXL2 mutation in granulosa-cell tumours of the ovary.

Authors:  Taeeun Kim; Chang Ohk Sung; Sang Yong Song; Duk-Soo Bae; Yoon-La Choi
Journal:  Histopathology       Date:  2010-02       Impact factor: 5.087

2.  Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.

Authors:  Min Sung Kim; Soo Young Hur; Nam Jin Yoo; Sug Hyung Lee
Journal:  J Pathol       Date:  2010-06       Impact factor: 7.996

3.  Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation.

Authors:  N Henriette Uhlenhaut; Susanne Jakob; Katrin Anlag; Tobias Eisenberger; Ryohei Sekido; Jana Kress; Anna-Corina Treier; Claudia Klugmann; Christian Klasen; Nadine I Holter; Dieter Riethmacher; Günther Schütz; Austin J Cooney; Robin Lovell-Badge; Mathias Treier
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

Review 4.  Management of granulosa cell tumour of the ovary.

Authors:  Stacey Jamieson; Peter J Fuller
Journal:  Curr Opin Oncol       Date:  2008-09       Impact factor: 3.645

Review 5.  Management of ovarian stromal cell tumors.

Authors:  Nicoletta Colombo; Gabriella Parma; Vanna Zanagnolo; Alessandra Insinga
Journal:  J Clin Oncol       Date:  2007-07-10       Impact factor: 44.544

6.  Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation.

Authors:  B A Benayoun; M Anttonen; D L'Hôte; M Bailly-Bechet; N Andersson; M Heikinheimo; R A Veitia
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

7.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.

Authors:  L Crisponi; M Deiana; A Loi; F Chiappe; M Uda; P Amati; L Bisceglia; L Zelante; R Nagaraja; S Porcu; M S Ristaldi; R Marzella; M Rocchi; M Nicolino; A Lienhardt-Roussie; A Nivelon; A Verloes; D Schlessinger; P Gasparini; D Bonneau; A Cao; G Pilia
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

8.  The transcriptional targets of mutant FOXL2 in granulosa cell tumours.

Authors:  Roseanne Rosario; Hiromitsu Araki; Cristin G Print; Andrew N Shelling
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

9.  The forkhead transcription factor FOXL2 is expressed in somatic cells of the human ovary prior to follicle formation.

Authors:  K Duffin; R A L Bayne; A J Childs; C Collins; R A Anderson
Journal:  Mol Hum Reprod       Date:  2009-08-25       Impact factor: 4.025

10.  The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.

Authors:  Kasmintan A Schrader; Bella Gorbatcheva; Janine Senz; Alireza Heravi-Moussavi; Nataliya Melnyk; Clara Salamanca; Sarah Maines-Bandiera; Susanna L Cooke; Peter Leung; James D Brenton; C Blake Gilks; John Monahan; David G Huntsman
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more
  5 in total

1.  FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells.

Authors:  Martina Belli; Nahoko Iwata; Tomoko Nakamura; Akira Iwase; Dwayne Stupack; Shunichi Shimasaki
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

2.  Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.

Authors:  Satoshi Yanagida; Michael S Anglesio; Tayyebeh M Nazeran; Amy Lum; Momoko Inoue; Yasushi Iida; Hirokuni Takano; Takashi Nikaido; Aikou Okamoto; David G Huntsman
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

3.  FOXO1 Negates the Cooperative Action of FOXL2C134W and SMAD3 in CYP19 Expression in HGrC1 Cells by Sequestering SMAD3.

Authors:  Martina Belli; Christian Secchi; Dwayne Stupack; Shunichi Shimasaki
Journal:  J Endocr Soc       Date:  2019-08-29

4.  FOXO1 mitigates the SMAD3/FOXL2C134W transcriptomic effect in a model of human adult granulosa cell tumor.

Authors:  Christian Secchi; Paola Benaglio; Francesca Mulas; Martina Belli; Dwayne Stupack; Shunichi Shimasaki
Journal:  J Transl Med       Date:  2021-02-27       Impact factor: 5.531

5.  RENIN-SECRETING OVARIAN ADULT GRANULOSA CELL TUMOR IN A PATIENT WITH NEW-ONSET HYPERTENSION AND HYPOKALEMIA.

Authors:  Rowan Karaman; Jin Xu; Ross F Harrison; David M Kushner; Paul S Weisman; Yoram Shenker
Journal:  AACE Clin Case Rep       Date:  2018-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.